The post examines key outcomes from a national conference on access to medicines in India, with a focus on pharmaceutical pricing, IPR, and related policy challenges. It analyses expert perspectives on affordable medicine, patent law, and healthcare systems in an Indian context.
Read more about ‘Affordability, Availability, Accessibility of medicines’